Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN 2012 /
Identifying targets with systems medicine

28th - 29th Jun 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.07.12
Views: 8745

Dr Leroy Hood – Institute for Systems Biology, USA

Dr Leroy Hood talks to ecancer at the 2012 WIN Symposium, Paris, about systems medicine, a new approach to understanding the complexities of cancer.


By analysing biological circuits at the proteomic and genomic level, observations can be made on when cancer cells form. The ultimate goal of this method is to identify targets efficiently and determine where and why mutations occur.


While many labs do not have access to the costly technologies to implement systems medicine, Dr Hood states that this method is what is needed to solve the current problems with cancer.


Filming supported by Amgen

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation